ANI Pharma (ANIP) Announces FDA Approval and Imminent Launch of Clorazepate Dipotassium Tablets USP

Go back to ANI Pharma (ANIP) Announces FDA Approval and Imminent Launch of Clorazepate Dipotassium Tablets USP
ANI PHARMACEUTICALS (NASDAQ: ANIP) Delayed: 76.36 -1.55 (1.99%)
Previous Close $77.91    52 Week High $70.92 
Open $77.00    52 Week Low $26.80 
Day High $78.86    P/E N/A 
Day Low $76.16    EPS $-0.96 
Volume 64,988